Next Science | Investor Centre

Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Reporting Calendar

Reporting date	Details of report
January	Q4 Activity & Cashflow Reports
February	Full Year Financial Report for previous year
April	Q1 Activity & Cashflow Reports. Annual Report
May	Annual General Meeting
July	Q2 Activity & Cashflow Reports
August	Half-Year Report
October	Q3 Activity & Cashflow Reports

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Automic
Level 5, 126 Phillip Street
Sydney NSW 2000
Email: [email protected]
Ph (within Australia): 1300 288 664
Ph (outside Australia): +61 2 9698 5414